No. of Recommendations: 1
https://finance.yahoo.com/quote/NVO/I believe Novo nordisk is currently the cheapest it has been in the last 5 years or so.
Adjusted for inflation, eyeballing it, it's about the cheapest it has been in over 10 years.
Of course, there might be good reasons for that.
I thought it looked good value at $48 and a very solid value play at $44.
It's now $36!
The risks are mildly scary.
- Patent cliff for 1-2 products that provide most of the income.
- Competitors product are basically better in efficacy.
- Trump being hostile to non-US companies and countries.
- Trump forcing down their price in the biggest market.
Despite that, the drop in the price might cover all those risks.
e.g. if you assign values to the weight loss business, the non-weight loss business, and their pipeline, what numbers do you get? I haven't checked. Maybe someone else might be interested to look into it.
TRS
